EGFR and non-small cell lung carcinoma: In addition, TP53 and RB1 alterations are frequently associated with small cell transformation in patients with EGFR-mutated NSCLC, and whether it is preexisting and/or potential treatment-emergent resistance clones is a matter of ongoing investigation.9